Artivion | CRY - سود ناخالص در فروش

قیمت سهام
35.29
تغییر روزانه
-1.10 -3.02%
ماهیانه
-8.46%
سالیانه
45.53%
Q1 پیش بینی
35.04




سود ناخالص در فروش تغییر دادن تاریخ
Abbott USD 6.54B 625M 2025-12
Accuray USD 41.89M 7.42M 2024-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Integra LifeSciences USD 217.1M 10.11M 2025-12
J&J USD 16.6B 118M 2025-12
Mesa Laboratories USD 39.75M 4.3M 2024-12
Orthofix International USD 153.28M 4.76M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
ResMed USD 878.72M 57.9M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Trinity Biotech USD 6.47M 1.59M 2025-09